Regencell Bioscience (RGC) has had the highest return since March 20, 2024 by a mid-cap US stock, returning 17,714.5%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 17,714.51% |
Power Solutions International, Inc Common Stock (PSIX) | 3,969.91% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Mercurity Fintech Holding Inc ADR (MFH) | 2,042.55% |
Quantum Computing (QUBT) | 1,679.49% |
Eos Energy Enterprises (EOSE) | 1,382% |
Innodata (INOD) | 1,376.86% |
GeneDx (WGS) | 1,367.58% |
Nano Nuclear Energy Inc Common Stock (NNE) | 1,206.67% |
Uniqure (QURE) | 1,066.73% |
Ondas (ONDS) | 1,048.98% |
CommScope (COMM) | 1,015.56% |
Centrus Energy (LEU) | 816.51% |
Mesoblast (MESO) | 770.04% |
Sezzle (SEZL) | 694.67% |
Terawulf (WULF) | 619.3% |
Verona Pharma PLC ADR (VRNA) | 598.76% |
Cidara Therapeutics (CDTX) | 586.96% |
Planet Labs PBC (PL) | 566.67% |
Applied Digital (APLD) | 549.77% |
Dave (DAVE) | 529.19% |
Perpetua Resources (PPTA) | 516.2% |
Abivax SA American Depositary Shares (ABVX) | 493.35% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 489.16% |
Nuscale Power (SMR) | 488.6% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
